Enanta Pharmaceuticals
ENTA
#7994
Rank
NZ$0.68 B
Marketcap
NZ$23.44
Share price
0.18%
Change (1 day)
114.90%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$96.07 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's total debt is NZ$96.07 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Enanta Pharmaceuticals - Total debt on balance sheet (from 2014 to 2026)

Total debt by year

Year Total debt Change
2025-09-30NZ$99.9 M14.29%
2024-09-30NZ$87.41 M97.66%
2023-09-30NZ$44.22 M-1.32%
2022-09-30NZ$44.81 M480.03%
2021-09-30NZ$7.72 M-36.82%
2020-09-30NZ$12.22 M3729.08%
2019-09-30NZ$0.31 M-27.8%
2018-09-30NZ$0.44 M-16.06%
2017-09-30NZ$0.52 M-27.95%
2016-09-30NZ$0.73 M-21.86%
2015-09-30NZ$0.93 M
2014-09-30N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$93.44 B 97,160.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$79.86 B 83,029.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$123.81 B 128,770.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$3.37 B 3,413.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$83.46 B 86,777.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$78.89 B 82,021.13%๐Ÿ‡บ๐Ÿ‡ธ USA